About this episode
Let’s Chat Tune in to hear how EKTA’s most recent research sparked a journey to discovering a breakthrough drug target that has been shown to help shrink skin tumors when it is blocked by pharmaceutically engineered molecules that block the protein known as AQUAPORIN 3 (AQP3) ! --- Send in a voice message: https://podcasters.spotify.com/pod/show/skincareanarchy/messageSupport this podcast: https://podcasters.spotify.com/pod/show/skincareanarchy/support Support the Show. Follow The Show On All Socials Using The Tag @skincareanarchy Hosted on Acast. See acast.com/privacy for more information.